MedTrace Logo

Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold

NCT02162056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 326

Last updated 2020-04-28

No results posted yet for this study

Summary

To evaluate the safety, performance and efficacy of the bioresorbable vascular scaffold (BVS) system in patients with coronary artery disease

Conditions

Interventions

DEVICE

use of bioresorbable vascular scaffolds

Implantation of bioresorbable vascular scaffolds for coronary artery disease.

Sponsors & Collaborators

  • University of Ulm

    lead OTHER

Principal Investigators

  • Jochen Wöhrle, MD · University of Ulm, Ulm, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02162056 on ClinicalTrials.gov